Last quarter (Q4 2022), Vyant Bio's total revenue was $41.00K, a decrease of -101.62% from the same quarter last year. In Q4, Vyant Bio's net income was $-4.26M. See Vyant Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20
Total Revenue	$ 661.00K	$ 567.00K	$ 1.15M	$ 867.00K
Cost of Revenue	$ 1.00M	$ 964.00K	$ 1.85M	$ 1.10M
Gross Profit	$ -342.00K	$ -342.00K	$ -699.00K	$ -234.00K
Operating Expense	$ 15.89M	$ 16.58M	$ 12.70M	$ 5.95M
Operating Income	$ -15.91M	$ -15.91M	$ -13.40M	$ -6.18M
Net Non Operating Interest Income Expense	$ 93.00K	$ 93.00K	$ -622.00K	$ -535.00K
Other Income Expense	$ -12.00K	$ -12.00K	$ 4.56M	$ -1.93M
Pretax Income	$ -15.81M	$ -15.81M	$ -18.57M	$ -8.65M
Tax Provision	-	-	$ -84.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -22.69M	$ -22.69M	$ -40.86M	$ -8.65M
Basic EPS	$ -8.54	$ -7.74	-	$ -3.48
Diluted EPS	$ -8.54	$ -7.74	$ -14.00	$ -3.48
Basic Average Shares	$ 46.65M	$ 5.87M	$ 4.52M	$ 2.49M
Diluted Average Shares	$ 46.65M	$ 5.87M	$ 2.92M	$ 2.49M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 16.89M	$ 17.54M	$ 14.54M	$ 7.05M
Net Income From Continuing And Discontinued Operation	$ -22.69M	$ -22.69M	$ -40.86M	$ -8.65M
Normalized Income	$ -8.73M	-	-	$ -6.71M
Interest Expense	$ 9.00K	-	-	$ 535.00K
EBIT	$ -15.90M	$ -15.90M	$ -18.20M	$ -6.18M
EBITDA	$ -15.06M	$ -15.06M	$ -17.15M	$ -5.07M

Currency in USD

Vyant Bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing